Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Keating

Showing results (351-360 of 436) with videos related to

Pageof 44
Sort By:
Blood Cancer Journal|September 3, 2016
ATM function and its relationship with ATM gene mutations in chronic lymphocytic leukemia with the recurrent deletion (11q22.3-23.2)Y Jiang, H-C Chen, X Su, et al.
Blood|July 1, 1992
Response assessment in chronic lymphocytic leukemia after fludarabine plus prednisone: clinical, pathologic, immunophenotypic, and molecular analysisL E Robertson, Y O Huh, J J Butler, et al.
Leukemia & Lymphoma|November 8, 2001
"T-cell-rich B-cell lymphoproliferative disorder" of the bone marrowR Aboul-Nasr, S O'Brien, E J Freireich, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1989
Response to salvage therapy and survival after relapse in acute myelogenous leukemiaM J Keating, H Kantarjian, T L Smith, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 26, 2016
Incidence and prognostic impact of other cancers in a population of long-term survivors of chronic lymphocytic leukemiaL Falchi, C Vitale, M J Keating, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1985
Intensive combination chemotherapy (ROAP 10) and splenectomy in the management of chronic myelogenous leukemiaH M Kantarjian, L Vellekoop, K B McCredie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1991
Fludarabine: a new agent with marked cytoreductive activity in untreated chronic lymphocytic leukemiaM J Keating, H Kantarjian, S O'Brien, et al.
Leukemia|October 27, 1997
Long-term follow-up results of alpha-interferon-based regimens in patients with late chronic phase chronic myelogenous leukemiaS Sacchi, H M Kantarjian, S O'Brien, et al.
Seminars in Hematology|January 1, 1994
Fludarabine phosphate: a new active agent in hematologic malignanciesM J Keating, S O'Brien, W Plunkett, et al.
Blood|November 1, 1991
Significance of the P210 versus P190 molecular abnormalities in adults with Philadelphia chromosome-positive acute leukemiaH M Kantarjian, M Talpaz, K Dhingra, et al.
Pageof 44

Showing results (351-360 of 436) with videos related to

Sort By:
Pageof 44
Blood Cancer Journal|September 3, 2016
ATM function and its relationship with ATM gene mutations in chronic lymphocytic leukemia with the recurrent deletion (11q22.3-23.2)Y Jiang, H-C Chen, X Su, et al.
Blood|July 1, 1992
Response assessment in chronic lymphocytic leukemia after fludarabine plus prednisone: clinical, pathologic, immunophenotypic, and molecular analysisL E Robertson, Y O Huh, J J Butler, et al.
Leukemia & Lymphoma|November 8, 2001
"T-cell-rich B-cell lymphoproliferative disorder" of the bone marrowR Aboul-Nasr, S O'Brien, E J Freireich, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1989
Response to salvage therapy and survival after relapse in acute myelogenous leukemiaM J Keating, H Kantarjian, T L Smith, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 26, 2016
Incidence and prognostic impact of other cancers in a population of long-term survivors of chronic lymphocytic leukemiaL Falchi, C Vitale, M J Keating, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1985
Intensive combination chemotherapy (ROAP 10) and splenectomy in the management of chronic myelogenous leukemiaH M Kantarjian, L Vellekoop, K B McCredie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1991
Fludarabine: a new agent with marked cytoreductive activity in untreated chronic lymphocytic leukemiaM J Keating, H Kantarjian, S O'Brien, et al.
Leukemia|October 27, 1997
Long-term follow-up results of alpha-interferon-based regimens in patients with late chronic phase chronic myelogenous leukemiaS Sacchi, H M Kantarjian, S O'Brien, et al.
Seminars in Hematology|January 1, 1994
Fludarabine phosphate: a new active agent in hematologic malignanciesM J Keating, S O'Brien, W Plunkett, et al.
Blood|November 1, 1991
Significance of the P210 versus P190 molecular abnormalities in adults with Philadelphia chromosome-positive acute leukemiaH M Kantarjian, M Talpaz, K Dhingra, et al.
Pageof 44